Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward

WAidid-EVASG Panel on vaccination of 50+

Research output: Contribution to journalReview article

Abstract

The proportion of the population ≥65 years old is about 17% today and will be about 27% in 2050 worldwide. The problem, however, is not ageing in itself, it is individual disabilities associated with ageing. This manuscript summarizes the consensus points reached during a pan-European meeting on gaps and barriers in making vaccination of adults aged 50+ a reality and on further joint actions in Europe. The shift from childhood to life-long vaccination is essential to prevent disability, morbidity and mortality in the elderly and promote healthy ageing. This vaccination shift is a major challenge in the post-truth, media-based era in countries with dwindling resources for the provision of healthcare. The challenge can be met only by adopting an innovative approach designed to shift the mindset of decision-makers from treatment to prevention. A number of key actions are required and for these actions a European multidisciplinary network including health authorities, medical doctors with different specialties, sociologists, psychologists, pharmaceutical companies and Associations of patients appears mandatory.

Original languageEnglish
Pages (from-to)5819-5824
Number of pages6
JournalVaccine
Volume36
Issue number39
DOIs
Publication statusPublished - Sep 18 2018

Fingerprint

Vaccination
vaccination
sociologists
physicians
childhood
health services
morbidity
Consensus
Psychology
Morbidity
Delivery of Health Care
drugs
Mortality
Health
Pharmaceutical Preparations
Population
Therapeutics

Keywords

  • Aged
  • Communicable Disease Control
  • Communicable Diseases/epidemiology
  • Congresses as Topic
  • Decision Making
  • Europe
  • Health Resources
  • Healthy Aging
  • Humans
  • Middle Aged
  • Preventive Health Services/trends
  • Vaccination/statistics & numerical data

Cite this

Vaccination of 50+ adults to promote healthy ageing in Europe : The way forward. / WAidid-EVASG Panel on vaccination of 50+.

In: Vaccine, Vol. 36, No. 39, 18.09.2018, p. 5819-5824.

Research output: Contribution to journalReview article

WAidid-EVASG Panel on vaccination of 50+. / Vaccination of 50+ adults to promote healthy ageing in Europe : The way forward. In: Vaccine. 2018 ; Vol. 36, No. 39. pp. 5819-5824.
@article{413a3241ae6d41a186cd8eee8ccf768f,
title = "Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward",
abstract = "The proportion of the population ≥65 years old is about 17{\%} today and will be about 27{\%} in 2050 worldwide. The problem, however, is not ageing in itself, it is individual disabilities associated with ageing. This manuscript summarizes the consensus points reached during a pan-European meeting on gaps and barriers in making vaccination of adults aged 50+ a reality and on further joint actions in Europe. The shift from childhood to life-long vaccination is essential to prevent disability, morbidity and mortality in the elderly and promote healthy ageing. This vaccination shift is a major challenge in the post-truth, media-based era in countries with dwindling resources for the provision of healthcare. The challenge can be met only by adopting an innovative approach designed to shift the mindset of decision-makers from treatment to prevention. A number of key actions are required and for these actions a European multidisciplinary network including health authorities, medical doctors with different specialties, sociologists, psychologists, pharmaceutical companies and Associations of patients appears mandatory.",
keywords = "Aged, Communicable Disease Control, Communicable Diseases/epidemiology, Congresses as Topic, Decision Making, Europe, Health Resources, Healthy Aging, Humans, Middle Aged, Preventive Health Services/trends, Vaccination/statistics & numerical data",
author = "{WAidid-EVASG Panel on vaccination of 50+} and Susanna Esposito and Nicola Principi and Giovanni Rezza and Paolo Bonanni and Gaetan Gavazzi and Ingo Beyer and Michael Sulzner and Celentano, {Lucia Pastore} and Roman Prymula and Andrea Rappagliosi and Joseph Sevilla and Gregory Poland",
note = "Copyright {\circledC} 2018 Elsevier Ltd. All rights reserved.",
year = "2018",
month = "9",
day = "18",
doi = "10.1016/j.vaccine.2018.08.041",
language = "English",
volume = "36",
pages = "5819--5824",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "39",

}

TY - JOUR

T1 - Vaccination of 50+ adults to promote healthy ageing in Europe

T2 - The way forward

AU - WAidid-EVASG Panel on vaccination of 50+

AU - Esposito, Susanna

AU - Principi, Nicola

AU - Rezza, Giovanni

AU - Bonanni, Paolo

AU - Gavazzi, Gaetan

AU - Beyer, Ingo

AU - Sulzner, Michael

AU - Celentano, Lucia Pastore

AU - Prymula, Roman

AU - Rappagliosi, Andrea

AU - Sevilla, Joseph

AU - Poland, Gregory

N1 - Copyright © 2018 Elsevier Ltd. All rights reserved.

PY - 2018/9/18

Y1 - 2018/9/18

N2 - The proportion of the population ≥65 years old is about 17% today and will be about 27% in 2050 worldwide. The problem, however, is not ageing in itself, it is individual disabilities associated with ageing. This manuscript summarizes the consensus points reached during a pan-European meeting on gaps and barriers in making vaccination of adults aged 50+ a reality and on further joint actions in Europe. The shift from childhood to life-long vaccination is essential to prevent disability, morbidity and mortality in the elderly and promote healthy ageing. This vaccination shift is a major challenge in the post-truth, media-based era in countries with dwindling resources for the provision of healthcare. The challenge can be met only by adopting an innovative approach designed to shift the mindset of decision-makers from treatment to prevention. A number of key actions are required and for these actions a European multidisciplinary network including health authorities, medical doctors with different specialties, sociologists, psychologists, pharmaceutical companies and Associations of patients appears mandatory.

AB - The proportion of the population ≥65 years old is about 17% today and will be about 27% in 2050 worldwide. The problem, however, is not ageing in itself, it is individual disabilities associated with ageing. This manuscript summarizes the consensus points reached during a pan-European meeting on gaps and barriers in making vaccination of adults aged 50+ a reality and on further joint actions in Europe. The shift from childhood to life-long vaccination is essential to prevent disability, morbidity and mortality in the elderly and promote healthy ageing. This vaccination shift is a major challenge in the post-truth, media-based era in countries with dwindling resources for the provision of healthcare. The challenge can be met only by adopting an innovative approach designed to shift the mindset of decision-makers from treatment to prevention. A number of key actions are required and for these actions a European multidisciplinary network including health authorities, medical doctors with different specialties, sociologists, psychologists, pharmaceutical companies and Associations of patients appears mandatory.

KW - Aged

KW - Communicable Disease Control

KW - Communicable Diseases/epidemiology

KW - Congresses as Topic

KW - Decision Making

KW - Europe

KW - Health Resources

KW - Healthy Aging

KW - Humans

KW - Middle Aged

KW - Preventive Health Services/trends

KW - Vaccination/statistics & numerical data

U2 - 10.1016/j.vaccine.2018.08.041

DO - 10.1016/j.vaccine.2018.08.041

M3 - Review article

C2 - 30143273

VL - 36

SP - 5819

EP - 5824

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 39

ER -